Home Itens selecionados Provedores de dados OAI Créditos Sobre Ajuda

			Busca avançada
	Provedor de dados BJMBR (2) Autor Guimarães,M.D.C. (2) Acurcio,F.A. (1) Bonolo,P.F. (1) Buzek,S.C. (1) Carmo,R.A. (1) Corrêa-Oliveira,R. (1) César,C.C. (1) Lima,A.A. (1) Menezes de Pádua,C.A. (1) Oliveira,G.C. (1) Oliveira,M.S. (1) Rocha,M.O.C. (1) Mais... Palavra-chave Adverse reactions to antiretroviral therapy (1) Antiretroviral therapy (1) Brazil (1) Chronic liver disease (1) HCV genotypes (1) Hemophilia (1) Hepatitis C virus (1) Medical records (1) Transfusion (1) Mais... Tipo do documento Info:eu-repo/semantics/article (2) Ano 2006 (1) 2002 (1) País Brazil (2) Idioma Inglês (2)		Ordenar por:  Relevância Autor Título Ano Registros recuperados: 2 Primeira ... 1 ... Última Hepatitis C virus infection among Brazilian hemophiliacs: a virological, clinical and epidemiological study BJMBR Carmo,R.A.; Oliveira,G.C.; Guimarães,M.D.C.; Oliveira,M.S.; Lima,A.A.; Buzek,S.C.; Corrêa-Oliveira,R.; Rocha,M.O.C.. We determined and analyzed risk factors of hepatitis C virus (HCV)-infected Brazilian hemophiliacs according to their virological, clinical and epidemiological characteristics. A cross-sectional and retrospective study of 469 hemophiliacs was carried out at a Brazilian blood center starting in October 1997. The prevalence of HCV infection, HCV genotypes and factors associated with HCV RNA detection was determined. The seroprevalence of anti-HCV antibodies (ELISA-3.0) was 44.6% (209/469). Virological, clinical and epidemiological assessments were completed for 162 positive patients. There were seven (4.3%) anti-HCV seroconversions between October 1992 and October 1997. During the same period, 40.8% of the positive anti-HCV hemophiliacs had abnormal alanine... Tipo: Info:eu-repo/semantics/article Palavras-chave: Hepatitis C virus; HCV genotypes; Hemophilia; Chronic liver disease; Transfusion; Brazil. Ano: 2002 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2002000500012 High incidence of adverse reactions to initial antiretroviral therapy in Brazil BJMBR Menezes de Pádua,C.A.; César,C.C.; Bonolo,P.F.; Acurcio,F.A.; Guimarães,M.D.C.. A concurrent prospective study was conducted from 2001 to 2003 to assess factors associated with adverse reactions among individuals initiating antiretroviral therapy at two public referral HIV/AIDS centers in Belo Horizonte, MG, Brazil. Adverse reactions were obtained from medical charts reviewed up to 12 months after the first antiretroviral prescription. Cox proportional hazard model was used to perform univariate and multivariate analyses. Relative hazards (RH) were estimated with 95% confidence intervals (CI). Among 397 charts reviewed, 377 (95.0%) had precise information on adverse reactions and initial antiretroviral treatment. Most patients received triple combination regimens including nucleoside reverse transcriptase inhibitors, non-nucleoside... Tipo: Info:eu-repo/semantics/article Palavras-chave: Antiretroviral therapy; Adverse reactions to antiretroviral therapy; Medical records. Ano: 2006 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2006000400010 Registros recuperados: 2 Primeira ... 1 ... Última

Empresa Brasileira de Pesquisa Agropecuária - Embrapa Todos os direitos reservados, conforme Lei n° 9.610 Política de Privacidade Área restrita		Embrapa Parque Estação Biológica - PqEB s/n° Brasília, DF - Brasil - CEP 70770-901 Fone: (61) 3448-4433 - Fax: (61) 3448-4890 / 3448-4891 SAC: https://www.embrapa.br/fale-conosco